Study Stopped
The registry was discontinued due to significant resources required.
Zenith® LP Abdominal Aortic Aneurysm (AAA) Post-Market Registry
Zenith® LP AAA Endovascular Graft Post-Market Registry
1 other identifier
observational
76
7 countries
15
Brief Summary
A registry to collect additional prospective intra-operative and follow-up information on physician use of the CE-marked Zenith® Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft under routine clinical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Typical duration for all trials
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 23, 2011
CompletedFirst Posted
Study publicly available on registry
August 26, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedOctober 11, 2012
October 1, 2012
2.1 years
August 23, 2011
October 10, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
graft patency and aneurysm exclusion
during (day 1) and after implantation through 12 months
Study Arms (1)
1
Interventions
Treatment of an abdominal aortic or aorto-iliac aneurysm with the CE-marked Zenith(R) Low Profile AAA Endovascular Graft.
Eligibility Criteria
Patients implanted with a CE-Marked Zenith® Low Profile AAA Endovascular Graft
You may qualify if:
- Patient is implanted with Zenith® Low Profile AAA Endovascular Graft
You may not qualify if:
- Patients for whom this device would not normally be considered standard of care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
AKH (General Hospital Vienna)
Vienna, Austria
UHZ Hamburg GmbH (Eppendorf University Hospital)
Hamburg, Germany
Klinikum rechts der Isar (RDI Munich)
Munich, Germany
Klinikum Nürnberg Süd
Nuremberg, Germany
Royal Victoria Hospital
Belfast, Ireland
Nuovo Ospendale Civile Sant' Agostino Estense di Baggiovara
Modena, Italy
Azoemda ospedaliera San Camillo Forlanini
Rome, Italy
Catharina Ziekenhuis
Eindhoven, Netherlands
Maastricht University Medical Center
Maastricht, Netherlands
St. Olav University Hospital
Trondheim, Norway
Guy's and St. Thomas' Hospital
London, United Kingdom
St. Mary's Hospital
London, United Kingdom
Manchester Royal Informary
Manchester, United Kingdom
Freeman Hospital
Newcastle upon Tyne, United Kingdom
Royal Gwent Hospital
Wales, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2011
First Posted
August 26, 2011
Study Start
July 1, 2010
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
October 11, 2012
Record last verified: 2012-10